Skip to content

In the BioHarmony Drug Report Database

Hexaminolevulinate

Cysview (hexaminolevulinate) is a small molecule pharmaceutical. Hexaminolevulinate was first approved as Cysview on 2010-05-28. Cysview's patent is valid until 2036-12-19 (FDA).
Trade Name Cysview
Common Name Hexaminolevulinate
Indication
Drug Class
Hexaminolevulinate
Get full access now